Navigation Links
Humacyte Presents Interim First-in-Human Data For Investigational Bioengineered Blood Vessel at the American Heart Association (AHA) Scientific Sessions 2013
Date:11/20/2013

rt a future application for regulatory approval.

About Humacyte

Humacyte, Inc., a privately held company founded in 2005, is a medical research, discovery and development company with clinical and pre-clinical stage investigational products. Humacyte is primarily focused on developing and commercializing a proprietary novel technology based on human tissue-based products for key applications in regenerative medicine and vascular surgery. The company uses its innovative, proprietary platform technology to engineer human, extracellular matrix-based tissues that are designed be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues. These are being developed for potential use in many specific applications, with the goal to significantly improve treatment outcomes for a variety of patients, including those with vascular disease and those requiring hemodialysis. The company's proprietary technologies are designed to result in off-the-shelf products that, once approved, can be utilized in any patient. The company web site is www.humacyte.com.

Forward-Looking Statement

Information in this news release contains "forward-looking statements" about Humacyte. These statements, including statements regarding management's projections relating to future results and operations, are based on, among other things, management's views, assumptions and estimates, developed in good faith, all of which are subject to known and unknown factors that may cause actual results, performance or achievements, or industry results, to differ materially from those expressed or implied by such forward-looking statements.

References

[1]https://www.kidney.org/kidneydisease/aboutckd.cfm
[2]http://www.ekha.eu/usr_img/info/factsheet.pdf
'/>"/>

SOURCE Humacyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
8. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
9. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
10. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
11. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  Corporate libraries are constantly being faced with ... technology and how to cope with flat or shrinking ... and medical device industries are increasingly finding it challenging ... they provide. According to recent research ... forces of change that leading corporate libraries are being ...
(Date:7/25/2014)... , July 25, 2014  In today,s marketplace, ... costly and challenging - as is managing a portfolio ... Is it possible - or even preferable - ... so, where can you combine resources and activities, and ... These are just a few of the ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems ... the Australia Capsule Endoscopy Systems market. The report provides ... and average prices (in US dollars) within market segments: ... , Capsule Endoscopes , Capsule Endoscopy Data ... The report also provides company shares and distribution shares ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... 2011 The " Global Fetal (Labor & ... global fetal and neonatal care equipment market by types and studies ... fetal and neonatal care market across 18 countries in North America, ... Explore market data tables and in-depth TOC on ...
... Incorporated (Nasdaq: VPHM ) today announced ... Pediatric Use Marketing Authorization (PUMA) for Buccolam® (midazolam, ... seizures in infants, toddlers, children and adolescents, from ... age.  This action by the European Commission represents ...
Cached Medicine Technology:MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 2MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 3MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 4ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 2ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 3ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 4ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 5
(Date:7/26/2014)... (PRWEB) July 26, 2014 The ... infrastructure has made companies choose cost-effective and distributed ... to a rise in the demand for System ... billion in 2013, expected to grow to $331.76 ... grow at a CAGR of 11.60% from 2013 ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Earlier this week, the ... would be performing at the 2014 iHeartRadio Music Festival ... in Las Vegas. Fans of every genre of music will have ... Country fans will enjoy the headlining act of Taylor Swift, as ... scream when they see One Direction, Ariana Grande, and Iggy Azalea, ...
(Date:7/26/2014)... The report “Gourmet Salts Market by Type ... Specialty Salt), Application (Bakery & Confectionery, Meat & Poultry ... Global Trend & Forecast to 2019” defines and segments ... the market size in terms of value and volume. ... the gourmet salts market, with detailed analysis of its ...
(Date:7/26/2014)... 2014 The European security and surveillance ... million in 2014, and it is expected to reach ... The report incorporates the factors that influence a country’s ... rates and projected total expenditure. The report also throws ... Apart from the general overview of the companies, it ...
(Date:7/26/2014)... The North America Cyber Security report defines and segments ... analysis and forecast of revenue. This market is estimated ... $33.24 billion by 2019, at a CAGR of 8.40% ... of the North America Cyber Security Market report to ... also provides a glimpse of the segmentation in this ...
Breaking Medicine News(10 mins):Health News:North America System Integration and Design Market is Expected to Reach $129.78 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America System Integration and Design Market is Expected to Reach $129.78 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America System Integration and Design Market is Expected to Reach $129.78 billion in 2018 - New Report by MicroMarket Monitor 4Health News:iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival for Sept. 19 & 20th 2Health News:iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival for Sept. 19 & 20th 3Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 2Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 3Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 4Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 4Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 5Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 4
... Colo., May 19 Mesa Laboratories,Inc. (Nasdaq: MLAB ) today ... 31, 2008., Highlights: -- Annual revenue increases 13% ... to a new record -- Annual net income increases 16% ... to a new record -- Fourth quarter operating income increases ...
... May 19 Today, the National,Disaster Search Dog ... trained canine-firefighter disaster search teams in the nation,announced ... ranch site in Santa,Paula, California, to build the ... Training Center (NTC) will allow SDF to help ...
... to advance knowledge of mysterious conditions , , MONDAY, May ... to help patients with mysterious health conditions that can,t ... Institutes of Health. , The Undiagnosed Diseases Program will ... NIH Clinical Center by doctors across the United States. ...
... treatment for head and neck cancer may help prevent ... study published in the May issue of Archives of ... , Treatment for head and neck cancer can be ... in the article. Psychiatric morbidity in these patients is ...
... The University of Texas Health Science Center at Houston ... people with a hard-to-treat form of a genetic bleeding ... results of pre-clinical tests appear in the May 2 ... a shortage of the blood-clotting protein Factor VIII (FVIII), ...
... changes drive increased deposits, MINNEAPOLIS, May 19 ... that Health Savings Accounts (HSAs) deposits,increased 41 percent year ... first time., Wells Fargo Health Benefit Services reported ... took advantage of higher 2007 contribution,limits before the April ...
Cached Medicine News:Health News:Mesa Labs Reports Record Year End Sales and Earnings 2Health News:Mesa Labs Reports Record Year End Sales and Earnings 3Health News:Mesa Labs Reports Record Year End Sales and Earnings 4Health News:Mesa Labs Reports Record Year End Sales and Earnings 5Health News:Mesa Labs Reports Record Year End Sales and Earnings 6Health News:National Disaster Search Dog Foundation Plans New Training Facility in Santa Paula, California 2Health News:U.S. Turns Spotlight on Medicine's Most Puzzling Cases 2Health News:Medication may prevent depression in patients with head and neck cancer 2Health News:Blood-clotting protein modified for people with hard-to-treat hemophilia 2Health News:Wells Fargo Health Savings Accounts Grow to Quarter-Billion Dollars 2
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The Aescula LV left-heart lead is a stylet-driven, silicone insulated lead with a titanium nitride (TiN) coated platinum-iridium electrode....
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
Medicine Products: